Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7698 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes

in response to

Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes

jonzobot

posted on Aug 29, 2023 01:39PM

Maybe this is the signal for the move forward, finally. Immunomedics was around for more than 30 years and languished down around $ .25 before being taken out for $21 billion ($84 a share) just a few years after that low.

Could this be our turn now? Is dreaming a strategy?

tada

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply